Skip to main content

Table 3 Immune-histochemical results and statistical analyses of AR considered as continuous variable: comparisons of cases vs controls in validation cohort

From: Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers

IHC parameter

Cases vs controls

(%)

N

Mean (%)

Median (%)

Range

pValue

AR

Cases

29

13.21

5

0–70

<  0.001

Controls

19

43.21

40

1–95

  1. AR Androgen Receptor
Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us